https://scholars.lib.ntu.edu.tw/handle/123456789/635386
Title: | Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE Study | Authors: | Miklos, David Bernard Abu Zaid, Mohammad Cooney, Julian P Albring, Jörn C Flowers, Mary Skarbnik, Alan P Yakoub-Agha, Ibrahim BOR-SHENG KO Bruno, Benedetto Waller, Edmund K Yared, Jean Sohn, Sang Kyun Bulabois, Claude-Eric Teshima, Takanori Jacobsohn, David Greinix, Hildegard Mokatrin, Ahmad Lee, Yihua Wahlstrom, Justin T Styles, Lori Socie, Gerard |
Issue Date: | 1-Apr-2023 | Journal Volume: | 41 | Journal Issue: | 10 | Start page/Pages: | 1876 | Source: | Journal of clinical oncology : official journal of the American Society of Clinical Oncology | Abstract: | To present primary and final analyses from the randomized, double-blind, placebo-controlled, phase III iNTEGRATE study, which evaluated the safety and efficacy of ibrutinib with prednisone in previously untreated patients with chronic graft-versus-host disease (cGVHD). |
URI: | https://pubmed.ncbi.nlm.nih.gov/36608310/ https://www.scopus.com/inward/record.uri?eid=2-s2.0-85151312872&doi=10.1200%2fJCO.22.00509&partnerID=40&md5=c981e5c7c8c6b3e9e6f3cc6715a76183 https://scholars.lib.ntu.edu.tw/handle/123456789/635386 |
ISSN: | 0732183X | DOI: | 10.1200/JCO.22.00509 |
Appears in Collections: | 醫學系 |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.